Make the Recruitment and Enrollment of Diverse Populations a Priority — and a Success
Use Case
Clinical
A sponsor planning a Phase II trial needs to identify US investigators who could support its study, understand the patient landscape associated with each investigator, and support goals and objectives outlined in its FDA Race & Ethnicity Diversity Plan. See Sitetrove in action.



To enable the booking feature, please enable all cookies in your browser.